Wema Hoover
Former Google Global Head of Diversity, Equity and Inclusion, DEI Global Thought Leader, Transformer of Cultures, and Executive Coach
James P. Allison
2018 Nobel Laureate in Physiology or Medicine | Inventor of Cancer Checkpoint Therapy | Founding Director, James P. Allison Institute, MD Anderson
James P. Allison didn't just win a Nobel Prize — he invented an entirely new way to treat cancer. By discovering how to release the immune system's built-in brakes, he created checkpoint immunotherapy, a field that has transformed outcomes for patients with melanoma, lung cancer, and beyond. Regental Professor and Founding Director of the James P. Allison Institute at MD Anderson, he brings one of medicine's most remarkable stories to the stage.
Want to book James P. Allison as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
James P. Allison biography
James P. Allison is the scientist who taught the immune system to fight cancer. A lifelong immunologist driven by pure scientific curiosity about T cells, he stumbled upon one of medicine’s most consequential discoveries: that disabling the immune system’s built-in “off switch” could unleash the body’s own defenses to eliminate tumors. That insight gave rise to an entirely new category of cancer treatment — immune checkpoint therapy — that has since extended or saved the lives of hundreds of thousands of patients worldwide.
Nobel Prize speaker James P. Allison is best known for identifying CTLA-4, a protein on T cells that functions as a molecular brake, suppressing immune activity and inadvertently allowing tumors to evade destruction. Rather than targeting the cancer itself, Allison recognized that blocking this brake with an antibody could free the immune system to attack tumors on its own terms. His landmark 1996 experiments demonstrated dramatic tumor elimination in animal models, and after years of persisting through pharmaceutical industry skepticism, that work led to ipilimumab (Yervoy) — the first immune checkpoint inhibitor approved by the FDA, cleared for advanced melanoma in 2011. Patients with a disease that once carried a median survival of less than a year were now surviving a decade or more.
Allison earned his Ph.D. from the University of Texas at Austin in 1973 and held faculty positions at UC Berkeley, Memorial Sloan Kettering, and the Parker Institute for Cancer Immunotherapy before joining the University of Texas MD Anderson Cancer Center in 2012, where he serves today as Regental Professor, Chair of Immunology, and Founding Director of the James P. Allison Institute. He is also a Howard Hughes Medical Institute Investigator and a longtime member of the Cancer Research Institute scientific advisory council.
2018 Nobel Prize in Physiology or Medicine
In 2018, Allison and Tasuku Honjo were jointly awarded the Nobel Prize in Physiology or Medicine for their discovery of cancer therapy by inhibition of negative immune regulation — a recognition of work that fundamentally redirected oncology from targeting tumors to targeting the immune system itself. His broader honors include the Albert Lasker Clinical Medical Research Award, the Breakthrough Prize in Life Sciences, the Canada Gairdner International Award, and election to the National Academy of Sciences and the National Academy of Medicine.
As a speaker, James P. Allison brings to the stage both the intellectual force of a scientist who changed medicine and the disarming candor of someone who spent years fighting to be heard. He speaks compellingly about the long arc from basic curiosity to clinical breakthrough, the courage required to pursue unconventional ideas, and the continuing frontier of combination immunotherapy. Audiences in oncology, life sciences, pharma, research philanthropy, and corporate innovation leave with a vivid understanding of what transformative science actually looks like — and why it so rarely follows the expected path.
James P. Allison Speaking Videos
Nobel Lecture: James Allison, Nobel Prize in Physiology or Medicine 2018
Keynote Speech by Nobel Prize Winner Dr. James P. Allison
James P. Allison Keynote Topics
Allison traces the scientific journey from a fundamental question about T cell biology to a Nobel Prize-winning breakthrough that gave rise to immune checkpoint therapy. He recounts how identifying CTLA-4 as an immune brake — and realizing it could be blocked — opened a door that the pharmaceutical industry was reluctant to walk through, and how persistence ultimately led to ipilimumab and a new era in oncology. A compelling account of curiosity-driven science producing outcomes that targeted cancer research alone could not have achieved.
Building on the foundation of checkpoint blockade, Allison examines the next frontier: why some patients respond dramatically while others do not, how combining immune checkpoint inhibitors improves outcomes, and what basic science still needs to uncover to make immunotherapy work for every patient. He draws on ongoing research at the James P. Allison Institute, where the integration of clinical trials and laboratory discovery is accelerating the path from insight to treatment.
A candid and personal reflection on what it means to pursue ideas that the field hasn't accepted yet. Allison discusses the years he spent presenting checkpoint data to audiences who didn't believe tumors could be immunologically rejected, the difficulty of finding a pharmaceutical partner, and the moment ipilimumab results made the scientific community take notice. Applicable to any organization navigating the tension between established thinking and the kind of disruptive ideas that actually move fields forward.
Allison makes a rigorous case for sustaining investment in fundamental, curiosity-driven research — arguing that immune checkpoint therapy, like most paradigm-shifting treatments, was not the product of a targeted drug development program but of a scientist asking basic questions about how T cells work. This keynote speaks directly to research funders, academic medical institutions, and corporate science leaders weighing the balance between applied and foundational research portfolios.
Speaker topics
FAQs on Booking James P. Allison
Why James P. Allison?
Booking James P. Allison for your event means hosting the scientist who invented a new way to treat cancer — and who fought for over a decade to make the world believe it. As the 2018 Nobel Laureate in Physiology or Medicine and founder of the field of cancer immunotherapy, Allison combines world-class scientific authority with a remarkably personal story of perseverance against institutional resistance. His talks resonate with audiences in oncology, biopharma, academic medicine, research foundations, and any organization that values bold, curiosity-driven innovation. He doesn't just explain checkpoint therapy — he makes the case for why science needs people willing to follow the evidence wherever it leads, even when no one else believes it yet. Contact Aurum Speakers Bureau to check availability and booking fees.
What did James P. Allison win the Nobel Prize for?
James P. Allison received the 2018 Nobel Prize in Physiology or Medicine, shared with Tasuku Honjo, for discovering cancer therapy by inhibition of negative immune regulation. Allison's contribution was identifying CTLA-4 as an inhibitory checkpoint on T cells — a molecular brake that cancer exploits to evade immune destruction. His 1996 experiments showed that blocking CTLA-4 with an antibody unleashed T cells to attack and destroy tumors in animal models, and that concept was ultimately translated into ipilimumab (Yervoy), the first FDA-approved immune checkpoint inhibitor, cleared for advanced melanoma in 2011. His work launched an entirely new category of cancer treatment that is now used across dozens of tumor types globally.
What is the James P. Allison Institute?
The James P. Allison Institute is a research and innovation center at the University of Texas MD Anderson Cancer Center, founded to advance the next generation of cancer immunotherapy. Led by Allison as Founding Director and his longtime research partner Padmanee Sharma as Director of Scientific Programs, the Institute integrates basic discovery, translational research, and clinical trials under one roof. Its mission is to bring the benefits of immunotherapy — still inaccessible to many cancer patients — to a far broader population, and to develop the scientific understanding needed to make combination therapies more effective and more predictable.
What topics does Nobel Prize speaker James P. Allison cover?
Allison speaks on the science and history of cancer immunotherapy, the discovery of CTLA-4 and immune checkpoint blockade, the future of combination immunotherapy, and the role of basic research in generating medical breakthroughs. He also addresses broader themes of scientific perseverance, the culture of curiosity-driven research, and what it takes to challenge prevailing dogma in medicine. His talks are particularly well suited to audiences in life sciences, oncology, biopharma, academic medicine, and research philanthropy. Reach out to Aurum Speakers Bureau to discuss the right format for your event.
How to book James P. Allison as a keynote speaker?
Aurum Speakers Bureau can help you book James P. Allison as a speaker for your next event, conference, or board meeting. Simply fill out our contact form to inquire about James P. Allison's availability for a speaking engagement. One of our booking agents will respond to your request immediately and contact the speaker to let them know you want to hire them. We will assist you with obtaining speaking fees, booking information, and confirming availability for James P. Allison or any other top keynote speaker or celebrity of your choice.
How much is James P. Allison speaking fee?
James P. Allison speaking fees are determined by several factors, including the event's date, whether it's a virtual or in-person event, the duration, format, preparation required for their speech, and more. The same applies to the cost to hire any other top expert speakers and celebrities. The Speaker Fee Range listed on our website is simply a guideline and is subject to change without notice. If you would like to hire James P. Allison to deliver a keynote speech for your event, please fill out the contact form or email us at info@aurumbureau.com with as much detail as possible. One of our experienced agents will get in touch with you and let you know exactly how much it will cost to book James P. Allison.
How can I contact James P. Allison?
We only work with James P. Allison on paid speaking engagements. Aurum Speakers Bureau can assist you in booking James P. Allison and will handle all negotiations, contracts, and logistics associated with having James P. Allison speak at your event. We will be your sole point of contact throughout the process. Get in touch with Aurum Speakers Bureau today, and we will reach out to any motivational speaker or celebrity you want to enquire about speaking at your event. If you wish to contact James P. Allison for any other reason, we will be unable to assist you as we are not authorized to provide personal contact information.
Can I book James P. Allison for a virtual keynote?
Yes, James P. Allison is available for virtual keynotes and webinars. To book James P. Allison for a virtual event, please complete the contact form or send us an email to inquire about the special fees for virtual engagements.
